A detailed history of Fifth Third Bancorp transactions in Natera, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 6,752 shares of NTRA stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,752
Previous 7,198 6.2%
Holding current value
$1.14 Million
Previous $779,000 10.14%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$97.75 - $129.67 $43,596 - $57,832
-446 Reduced 6.2%
6,752 $858,000
Q2 2024

Jul 22, 2024

BUY
$85.28 - $112.6 $65,324 - $86,251
766 Added 11.91%
7,198 $779,000
Q1 2024

Apr 23, 2024

BUY
$59.21 - $92.9 $12,789 - $20,066
216 Added 3.47%
6,432 $588,000
Q4 2023

Jan 19, 2024

BUY
$37.55 - $62.64 $6,721 - $11,212
179 Added 2.97%
6,216 $389,000
Q3 2023

Oct 31, 2023

SELL
$43.4 - $62.52 $954 - $1,375
-22 Reduced 0.36%
6,037 $267,000
Q2 2023

Jul 25, 2023

BUY
$47.08 - $55.16 $285,257 - $334,214
6,059 New
6,059 $294,000
Q2 2022

Aug 04, 2022

SELL
$28.13 - $44.54 $171,311 - $271,248
-6,090 Closed
0 $0
Q1 2022

Apr 19, 2022

BUY
$30.32 - $91.33 $24,407 - $73,520
805 Added 15.23%
6,090 $248,000
Q4 2021

Feb 01, 2022

BUY
$86.26 - $119.0 $26,999 - $37,247
313 Added 6.3%
5,285 $494,000
Q3 2021

Oct 15, 2021

BUY
$100.17 - $126.36 $9,916 - $12,509
99 Added 2.03%
4,972 $554,000
Q2 2021

Aug 06, 2021

BUY
$86.05 - $119.72 $16,435 - $22,866
191 Added 4.08%
4,873 $553,000
Q1 2021

May 07, 2021

BUY
$91.47 - $124.36 $30,550 - $41,536
334 Added 7.68%
4,682 $475,000
Q4 2020

Feb 16, 2021

BUY
$66.66 - $111.74 $129,453 - $216,999
1,942 Added 80.71%
4,348 $433,000
Q3 2020

Nov 09, 2020

BUY
$45.89 - $72.67 $110,411 - $174,844
2,406 New
2,406 $174,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.